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Abstract
Clostridium difficile is responsible for a wide spectrum of infection from asymptomatic car-
riage to severe, relapsing colitis. Since 2003, C. difficile infections have increased with a
higher morbidity and mortality due to the emergence of epidemic and hypervirulent C. diffi-
cile strains such as those of the epidemic lineage 027/BI/NAP1. To decipher the hyperviru-
lence and epidemicity of 027 strains, we analyzed gene expression profiles of the R20291
027 strain using a monoxenic mouse model during the first 38h of infection. A total of 741
genes were differentially expressed during the course of infection. They are mainly distrib-
uted in functional categories involved in host adaptation. Several genes of PTS and ABC
transporters were significantly regulated during the infection, underlying the ability of strain
R20291 to adapt its metabolism according to nutrient availability in the digestive tract. In this
animal model, despite the early sporulation process, sporulation efficiency seems to indi-
cate that growth of R20291 vegetative cells versus spores were favored during infection.
The bacterial mechanisms associated to adaptability and flexibility within the gut environ-
ment, in addition to the virulence factor expression and antibiotic resistance, should contrib-
ute to the epidemicity and hypervirulence of the C. difficile 027 strains.
Introduction
Clostridium difficile is a Gram positive, spore forming, anaerobic bacterium and is the major
cause of nosocomial intestinal disease associated with antibiotic therapy. C. difficile infection
(CDI) has reached an epidemic state with increasing incidence and severity both in healthcare
and community settings. This rise in morbidity and mortality results from emergence of the C.
difficile epidemic lineage 027/BI/NAP1, whose strains have spread throughout developed coun-
tries [1,2]. The spectrum of infection, ranging from asymptomatic carriage to fulminant
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relapsing colitis, depends on C. difficile virulence factors, the fitness of the bacteria within the
gastrointestinal tract and host susceptibility.
The pathogenesis of CDI begins by the disruption of the normal colonic microbiota by anti-
biotics allowing the germination of contaminating spores and the colonization of the gastroin-
testinal tract by vegetative forms [3]. Several C. difficile surface proteins potentially function as
colonization factors. Thus it has been shown that the two S-layer subunits [4], the Cwp66 pro-
tein [5], the fibronectin-binding protein Fbp68 [6], the collagen-binding protein CbpA [7] and
the lipoprotein CD0873 [8] all play a role in the adherence of bacteria to the epithelial cells. In
addition, flagellar proteins also display adhesive properties [9] while proteases such as Cwp84
or Zmp1 may participate in the dissemination of the bacteria [10–12]. The last step corre-
sponds to the production of the major virulence factors of C. difficile, the toxins TcdA and
TcdB that modify the actin skeleton of the intestinal cells by glucosylation of the Rho proteins
[13–16]. A third toxin, the binary toxin is produced by some strains such as the 027 strains,
which possibly potentiates toxicity of TcdA and TcdB, and leads to more severe diseases [17].
The epidemic features of the 027 strains might be explained by their antibiotic resistance
profile and sporulation rates [18,19], while sporulation characteristics vary according to experi-
mental conditions and isolates [20]. In addition, the 027 strains exhibit a higher production of
toxins [19,21,22], although the mechanism is not clearly understood. Nevertheless, the hyper-
virulence of these strains is still not fully understood.
In order to improve our knowledge of the hypervirulence mechanisms of the 027 strains, we
analyzed the genome-wide temporal expression of the 027 strain R20291 using a monoxenic
mouse model during the first 38h of infection. This animal model was previously successfully
applied to decipher some of the adaptation mechanisms of C. difficile strain 630 in the host
[12]. Here, we analyzed the kinetics of gene expression of strain R20291 at 4, 6, 8, 14 and 38h
post infection. We found that 741 genes were regulated during in vivo growth. The modulation
of expression mainly concerned transport, metabolism and sporulation genes. This work led to
new insights into adaptation strategies used by the 027 strains during the infection process.
Material and Methods
Bacterial strains and growth conditions
Strain R20291 (Wild-type BI/NAP1/027 Stoke Mandeville isolate, gift from N. Minton, Univer-
sity of Notthingham, UK) was cultured in peptone yeast (PY) agar or broth (Oxoid) in an
anaerobic atmosphere (10% CO2, 10% H2, 80% N2) at 37°C. Sporulation assays were per-
formed from cell cultures grown in BHIS (brain heart infusion containing 5 mg ml-1 yeast
extract [AES] and 0.1% [w/v] L-cysteine [Merck]). After heat shock treatment (60°C, 30 min),
spores were quantified (CFU/ml) on BHIS agar supplemented with 0.1% sodium taurocholate
to induce germination.
Gnotobiotic mouse model
Animal care and experiments were carried out in accordance with the Committee for Research
and Ethical Issues of the International Association for the Study of Pain (IASP). The Animal
Welfare Committee of the Paris Sud University approved the animal experimentation protocol.
C3H/HeN germ-free 6–8 week old mice (CNRS, Orléans, France), housed in sterile isolators,
received sterilized standard nutrients and water. Groups of 6 axenic mice were challenged by
oral gavage with 1x108 CFUs of R20291 vegetative cells (spore rate less than 0.1% of vegetative
cells) from early stationary phase [23]. After challenge with C. difficile, the monoxenic-associ-
ated mice did not exhibit symptoms indicative of severe illness and survived the entire experi-
ment. Mice were humanely euthanized according to the guidelines of the "The Animal Welfare
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Committee of the Paris Sud University" at 4h, 6h, 8h, 14h and 38h, and cecal contents were col-
lected. Another group of 6 mice was used to measure C. difficile fecal shedding from 4h to 148h
post-infection by plating fecal dilutions either on BHI (for vegetative cell enumeration) or after
a heat shock treatment (60°C, 30 min) on BHI supplemented with 0.1% of sodium taurocholate
(for spore enumeration). The toxin production was measured in the cecal contents of mice
qualitatively with the "RidascreenR Clostridium difficile ToxinA/B (r-biopharm) and quantita-
tively with a cell cytotoxicity assay.
RNA extraction
Bacterial RNA was extracted from the cecal contents recovered at the different times, as previ-
ously described [12]. Both RNA quality and quantity were analyzed on the Bionalyser Agilent
2100 and RNA 6000 Nano Reagents (Agilent) and by qPCR on housekeeping genes gyrA and
rpoA. According to the amount of RNA extracted and its quality (RINs>7), the four best sam-
ples per time point were used for transcriptomic analysis.
Reverse transcription and microarray hybridizations
The microarray of C. difficile R20291 genome (GEO database accession number GPL15218)
was designed as previously described [23]. Competitive hybridization assays and data analysis
were performed as previously described [23]. A gene was considered as differentially expressed
when the p-value was<0.05. The complete data set was deposited in the GEO database with a
series record accession number GSE35726: http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?
acc=GSE35726.
Real-time reverse transcription PCR (qRT-PCR) analysis of gene
expression
Quantitative RT-PCR was performed as indicated previously [23] to confirm the regulation of
14 selected genes. The results were normalized using the geometric averaging of 4 reference
genes (polII, rrs, rpoA and gyrA). Normalized relative quantities were calculated using the
ΔΔCT method. The Mann-Whitney test was performed using StatEL software to determine
statistical significant difference (p< 0.05).
Results
Global analysis of strain R20291 gene expression during in vivo growth
A total of 741 genes exhibited differential expression during the course of mouse infection.
Among these genes, 285 genes were upregulated (fold change 2) while 456 were downregulated
(fold change 0.5) at early (4-6h) and/or late (14-38h) infection time relative to 8h post-chal-
lenge (Table A in S1 File). All genes found differentially expressed were then assigned to func-
tional categories. The classification was done manually on differentially expressed operons using
the functional categories defined previously [12] (Fig 1). The results of the qRT-PCR experiments
performed on 14 selected genes confirmed the trends observed by the microarray data with a
high correlation coefficient (R = 0.83) (Fig 2, Table B in S1 File) and validated the transcriptomic
profile data. All biological processes whose constituent genes were either up- or down-regulated
could have a possible role in survival in vivo, and thus were given special attention.
Expression of genes encoding virulence factors
Transcriptional profiles of toxin genes only showed a significant upregulation of tcdA and tcdB
at 38h post-infection. In addition, tcdE was upregulated simultaneously at 38h, which supports
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the late release of toxins during growth [24]. This is consistent with in vitro results showing
that toxin genes are expressed at a late stage of growth in response to the environmental status
[25]. In our experiments, toxins were positive in the cecal samples with a cytotoxicity titer
1:40000 at 48h post-infection. Interestingly, genes encoding the binary toxin were induced
early (8h) and were constitutively expressed thereafter (Table 1 and Table B in S1 File).
Several genes encoding surface proteins and known colonization factors such as slpA,
cwp66, cwp84, fbpA and cpbA were either not expressed or not differentially regulated during
the course of infection. However, the CDR0802 (CD630_08730) gene, encoding a surface pro-
tein involved in the adhesion process [8], was highly up- and down-regulated over time, with a
gradual upregulation from 6h to 14h, followed by a downregulation at 38h post-challenge
(Table C in S1 File). In addition, some genes encoding surface proteins with unknown or
Fig 1. Functional clusters of in vivo differentially expressed genes (p-value < 0.05) in theC. difficile
strain R20291.Genes were classified in functional groups according to functions. Black and grey bars
represent respectively up-regulated and down-regulated genes. (A) Regulated genes at 4 and 6h compared
to 8h. (B) Regulated genes at 14 and 38h compared to 8h.
doi:10.1371/journal.pone.0158204.g001
Fig 2. Validation of microarray data by qRT-PCR. Fold changes in in vivo gene expression at 4, 6, 14 and
38h post-infection, compared to the in vivo expression at 8h post-infection, were measured by microarray and
qRT-PCR. Data are plotted as log2 ratios of microarrays data (x-axis) compared with those of qRT-PCR (y-
axis).
doi:10.1371/journal.pone.0158204.g002
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putative function were differentially regulated during the growth such as cwp25 (CDR0774)
and cwp10 (CDR2685) upregulated early and late, respectively, and the gene coding for a puta-
tive fibronectin-binding protein (CDR2686), upregulated at 4h and 38h post-infection
(Table C in S1 File). Surprisingly, flagellar and type IV pilus encoding genes were not regulated
during in vivo infection.
Expression of transport and metabolism encoding genes
Many genes involved in metabolic functions were upregulated during mouse infection and
especially those involved in membrane transports and carbohydrate, lipid and amino acid
metabolism (Tables A, D and E in S1 File).Most of the PTS genes of strain R20291 were not
regulated in vivo. However, we found that genes coding for two PTS systems of the lactose/cel-
lobiose family (CDR0133-0137, CDR3263-3267) were upregulated early (4h and 6h, respec-
tively) while others were expressed late. Among the latter, we found that genes encoding two
PTS glucose-like (CDR2401-2404, CDR2862-2866) and one PTS mannose/fructose operon
(CDR3136-3140) were upregulated at 14-38h and 38h, respectively. Interestingly, the gatABC
genes (CDR2214-2216) of the PTS galactitol and gatD (CDR2213) encoding a galactitol dehy-
drogenase, were highly upregulated early and late during infection. Galactitol is produced by
reducing galactose and is then converted by gatD to D-tagatose-6-phosphate. Interestingly, we
noted that a PTS tagatose system (CDR2913-2915) was also upregulated during early coloniza-
tion (Table D in S1 File). In Enterobacteriaceae, these two pathways generate glyceraldehyde-
phosphate (GAP) and dihydroxyacetone-phosphate (DHAP) that could be used through the
glycolysis pathway to generate pyruvate and ATP [26]. Thus, according to their availability in
the gut, strain R20291 may have a preferred use of carbohydrate sources to produce pyruvate
during the course of the infection.
Pyruvate is then metabolized by various fermentation pathways for energy production or
used for anabolic reactions. We found that genes encoding enzymes involved in the synthesis
of acetyl-coenzyme A (acetyl-CoA), i.e. indolepyruvate ferredoxin oxidoreductase (CDR2267-
2268) and the putative ferredoxin/flavodoxin oxidoreductases (CDR0115-0117 and CDR2318-
2320), were downregulated at 4h and 38h (Table D in S1 File), suggesting that they were
expressed at the mid-phase (6-14h) of the colonization. In addition, we observed that genes
encoding enzymes involved in the conversion of acetyl-CoA into butyryl-CoA via an interme-
diary of crotonyl-CoA (CDR0910-0915) were constitutively expressed since they are downre-
gulated at 38h. Moreover, several gene clusters encoding enzymatic pathways involved in the
final synthesis of butyrate from butyryl-CoA (CDR2314-2317; CDR2565-2567) or acetate
Table 1. Regulation of toxin genes during the kinetics of infection.
Gene ID CDR20291 Gene ID CD630 Gene name Gene product description Fold change compared to 8h
4h 6h 8h 14h 38h
CDR0581 CD0659 tcdR Alternative RNA polymerase sigma factors 1.00 1.00 1.00 1.00 1.00
CDR0582 CD0660 tcdB Toxin B 1.00 1.00 1.00 1.00 4.53
CDR0583 CD0661 tcdE Holin-like pore-forming protein 1.00 1.00 1.00 1.00 1.96
CDR0584 CD0663 tcdA Toxin A 0.47 1.00 1.00 1.00 2.87
CDR0585 CD0664 tcdC Negative regulator of toxin gene expression 1.00 1.00 1.00 1.00 1.00
CDR2490 cdtR Binary toxin regulatory gene LytTR family 1.00 1.00 1.00 1.00 1.00
CDR2491 cdtA Fragment of ADP-ribosyltransferase 1.00 1.00 1.00 1.00 1.00
CDR2492 cdtB Fragment of ADP-ribosyltransferase 0.27 0.29 1.00 1.00 1.00
Genes upregulated or downregulated by a fold change of 1.5 or more are in bold
doi:10.1371/journal.pone.0158204.t001
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(CDR2564-2567) were differentially regulated during the course of infection. However, they all
showed a downregulation at 38h (Fig 3, Table D in S1 File), suggesting a coordinate decreased
production of butyrate at 38h. Among the other genes differentially regulated in vivo and asso-
ciated with the carbohydrate metabolism, we found that genes encoding the ribose-5-phos-
phate isomerase (CDR2209) and the transketolase (CDR2210-2211) involved in the pentose
phosphate pathway and in connection with the glycolytic pathway, respectively, were upregu-
lated early (4-6h) and late (38h) during infection (Table D in S1 File).
Several ABC transporters were upregulated late during the course of infection (Tables A
and E in S1 File). Of particularl interest, operons appABC and appDF encoding oligopeptide
transporters (CDR2558-2562) and genes encoding cystein transporter (CDR2080-2083) or
multidrug transporter (CDR1501-1503) were upregulated at 14h and 38h. Peptide and amino-
acid assimilation by the cell can be used as carbon and nitrogen sources and metabolized
through the Stickland reaction to produce ATP and to regenerate the redox status [25]. In con-
trast, the operons opuCA and opuCC encoding Glycine betaine ABC transporter (CDR0830-
0831) were first upregulated early (6h), but were then downregulated at 38h. Glycine betaine is
an excellent osmoprotectant and is widely used by prokaryotes as an adaptive strategy to high
osmolarity environment, such as gut content [27].
Stress response genes
During infection, C. difficile encounters several environment stresses and must adapt to them.
This requires a wide range of mechanisms, involving tightly regulated and coordinated protein
expression. The more striking result was the late 38h upregulation of several genes encoding
class I Heat Shock Proteins (HSP), such as dnaJ, dnaK and gprE (CDR2353-2355), and the reg-
ulatory gene hcrA (CDR2356) (Table A in S1 File). This is consistent with a comparative prote-
omic study performed by Chen et al. [28], that shows that epidemic 027 strain R20291 has a
Fig 3. Gene regulation in the fermentation pathway involved in the production of butyrate, butanol
and ethanol.
doi:10.1371/journal.pone.0158204.g003
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more robust stress response than the historic non-epidemic 027 strain (CD196), which might
explain why the epidemic 027 strains adapt better during colonization.
Sporulation genes
Several genes involved in different stages of the sporulation process were regulated during mice
infection (Table 2). Among them, we found that expression of spo0A gene coding for the main
transcriptional regulator of sporulation [29] was upregulated early (6h) before being downre-
gulated at 38h, suggesting that in vivo the sporulation process begins early for strain R20291.
Accordingly, some genes known to be dependent on Spo0A, such as spoIIA operon coding for
the sporulation sigma factor σF (CDR0701) and proteins that control its activity in the forespore
(CDR0699 and CDR0700), were regulated similarly (Table 2). The other sporulation-specific
sigma factors σE (CDR2531) and σG (CDR2530), controlling gene expression in the mother cell
and in the forespore, respectively, were mainly expressed à 8h post-infection (Table 2). In agree-
ment, expression of the σE-dependent spoIIIA operon (CDR1030-CDR1037), encoding an
ATPase and membrane proteins localized in the outer membrane of the forespore was also simi-
larly upregulated at 8h post-infection, as well as some σG dependent genes like sspA (CDR2576)
and sspB (CDR3107), encoding small acid-soluble proteins (SASP) which are responsible for the
protection of the forespore chromosome. Late upregulated genes mainly belong to the sigK regu-
lon [30,31]. This concerns genes encoding dipicolinate synthase subunits (CDR2802-2803) and
spore surface proteins encoding genes (Table 2). For instance, cotJA, cotJB1 encoding spore coat
proteins and cotCB encoding a putative manganese catalase present in the coat were highly upre-
gulated. Similarly, expression of bclA genes encoding exosporium glycoproteins and cdeC encod-
ing a cysteine-rich exosporium protein were upregulated late during infection (Table 2).
Specific R20291 genes
The 027 genomes have 234 additional genes compared to the 630 genome [32,33], including
genes of a 20 kb phage island, and several transcriptional regulators, among them, a complete
copy of an agr system named agr2. Our transcriptomic analysis did not show clear modulation
of specific 027 gene expression during the course of infection. In particular, neither genes
belonging to the phage island nor genes coding for the Agr2 system, were regulated in vivo.
However, we cannot exclude that they are steadily expressed over time since they have been
shown to contribute to the fitness and the virulence potential of the C. difficile 027 strains [34].
Finally, the thyA gene and the associated genes (CDR0044, 0045, 0047) were upregulated early
(4h) and constitutively expressed thereafter (Table A in S1 File). The thyX gene present in
strain 630, is replaced in strain R20291 by the thyA gene coding for a thymidylate synthase
involved in the synthesis of dTMP with a much more efficient activity [35,36].
Discussion
For this in vivo study, we used the monoxenic mouse model in the same environmental condi-
tions than for the in vivo transcriptional profiling performed previously with strain 630 [12].
This allows proceeding to some comparisons, which highlight the differences between the two
strains regarding their adaptation to the host. As already observed with strain 630, genes of
strain R20291 involved in metabolic functions, transport, stress response or coding for proteins
with unknown functions, were the most regulated genes during the in vivo kinetic study.
The gut colonization by C. difficile is a prerequisite of the C. difficile infection process before
toxin production [3]. We found that among genes encoding surface proteins in strain R20291,
the adhesin CDR0802 was upregulated during the course of intestinal colonization (Table B in
S1 File), which was not the case in strain 630 [12]. This difference may account for the better
In Vivo C. difficile 027 Transcriptomics
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adherence of strain R20291 to the Caco-2 cells compared to strain 630 [37]. In contrast, the
slpA gene encoding the S-layer proteins involved in in vitro adherence [4,38] was upregulated
Table 2. Regulation of sporulation and germination genes during the kinetics of infection.
Gene ID CDR20291 Gene ID CD630 Gene Name Gene product description Fold change compared to 8h
4h 6h 8h 14h 38h
CDR0123 CD0124 spoIIC Stage II sporulation protein C 0.42 0.24 1.00 1.00 0.45
CDR0125 CD0126 spoIIID Stage III sporulation protein D 0.11 0.12 1.00 0.32 0.15
CDR0521 CD0596 cotJA Hypothetical protein 1.00 1.00 1.00 72.50 54.30
CDR0522 CD0597 cotF Spore coat protein 1.00 1.00 1.00 74.91 66.46
CDR0523 CD0598 cotCB Spore coat protein CotCB manganese catalase 1.00 1.00 1.00 66.46 59.32
CDR0699 CD0770 spoIIAA Anti-sigma F factor antagonist 0.08 1.00 1.00 1.00 0.26
CDR0700 CD0771 spoIIAB Anti-sigma F factor 0.10 1.00 1.00 1.00 0.28
CDR0701 CD0772 sigF RNA polymerase sigma-F factor 0.20 1.00 1.00 1.00 0.31
CDR0702 CD0773 spoVAC stage V sporulation protein AC 0.24 0.26 1.00 1.00 1.00
CDR0703 CD0774 spoVAD stage V sporulation protein AD 0.31 0.29 1.00 1.00 0.33
CDR0704 CD0775 spoVAE stage V sporulation protein AE 0.39 0.43 1.00 1.00 1.00
CDR0714 CD0783 spoIVB Stage IV sporulation protein SpoIVB, 55 peptidase family 1.00 1.00 1.00 1.00 3.05
CDR0926 CD1067 cdeC Cysteine-rich exosporium protein 0.10 0.08 1.00 10.15 7.42
CDR1030 CD1192 spoIIIAA Stage III sporulation protein AA 0.14 0.26 1.00 0.34 0.15
CDR1031 CD1193 spoIIIAB Stage III sporulation protein AB 0.22 0.20 1.00 0.30 0.28
CDR1032 CD1194 spoIIIAC Stage III sporulation protein AC 0.20 0.20 1.00 0.26 0.22
CDR1033 CD1195 spoIIIAD Stage III sporulation protein AD 0.18 0.18 1.00 0.24 0.17
CDR1034 CD1196 spoIIIAE Stage III sporulation protein AE 0.23 0.24 1.00 0.27 0.22
CDR1035 CD1197 spoIIIAF Stage III sporulation protein AF 0.30 0.27 1.00 0.34 0.34
CDR1036 CD1198 spoIIIAG Stage sporulation protein AG 0.05 0.06 1.00 0.26 0.09
CDR1037 CD1199 spoIIIAH Stage III sporulation protein AH 0.06 0.07 1.00 0.26 0.10
CDR1052 CD1214 spo0A Stage 0 sporulation protein A 0.25 1.00 1.00 1.00 0.40
CDR1511 CD1613 cotA Spore outer coat layer protein 1.00 1.00 1.00 19.35 15.89
CDR1529 CD1631 sodA Spore coat superoxyde dismutase 0.26 0.27 1.00 1.00 1.00
CDR1858 CD1935 spoVS stage V sporulation protein S 0.20 1.00 1.00 1.00 0.34
CDR2290 CD2400 cotJB2 Spore coat protein JB 2 0.16 0.15 1.00 5.98 1.00
CDR2291 CD2401 cotD Putative manganese catalase 0.16 0.16 1.00 6.89 3.91
CDR2334 CD2442 spoIV Stage IV sporulation protein 0.28 0.29 1.00 1.00 0.35
CDR2362 CD2469 spoIIP Stage II sporulation protein P 0.25 0.23 1.00 0.37 0.24
CDR2363 CD2470 gpr Spore endodpeptidase 0.22 0.26 1.00 0.36 0.21
CDR2513 CD2629 spoIVA Stage IV sporulation protein A 0.04 0.04 1.00 0.31 0.09
CDR2530 CD2642 sigG Sporulation sigma factor G 0.06 0.09 1.00 0.25 0.10
CDR2531 CD2643 sigE Sporulation sigma factor E 0.13 0.19 1.00 0.25 0.17
CDR2532 CD2644 spoIIGA Sporulation sigma factor E processing peptidase 0.29 0.34 1.00 0.34 0.29
CDR2576 CD2688 sspA Small acid-soluble spore protein A 0.02 0.01 1.00 1.00 1.00
CDR2802 CD2967 spoVFB Dipicolinate synthase subunit B 0.33 0.33 1.00 2.50 1.00
CDR2803 CD2968 dpaA Dipicolinate synthase subunit B 0.28 0.29 1.00 2.59 1.00
CDR3090 CD3230 bclA2 Exosporium glycoprotein 1.00 1.00 1.00 5.96 3.15
CDR3107 CD2688 sspB small acid-soluble spore protein B 0.04 0.03 1.00 1.00 1.00
CDR3193 CD3349 bclA3 Putative exosporium glycoprotein 0.24 0.26 1.00 5.69 1.00
CDR3327 CD3490 spoIIE Stage II sporulation protein E 0.01 0.09 1.00 0.36 0.09
CDR3401 CD3564 spoIIR Stage II sporulation protein R 0.35 0.31 1.00 1.00 0.36
CDR3404 CD3567 sipL SpoIVA interacting protein 0.05 0.05 1.00 0.36 0.10
CDR3336 CD3499 spoVT stage V sporulation protein S 0.09 0.09 1.00 0.34 0.14
CDR3353 CD3516 spoVG stage V sporulation protein G 0.22 1.00 1.00 1.00 0.44
Genes upregulated or downregulated by a fold change of 1.5 or more are in bold
doi:10.1371/journal.pone.0158204.t002
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early in monoxenic mice for strain 630 [12] but not for strain R20291. These differences under-
line the relative importance of adhesins according to strains.
Our results showed that toxin genes were upregulated late, as already observed in strain 630
using the same animal model [12], but differ from those obtained in the pig ligated loop model
where toxin production was induced early [39]. These differences are in agreement with the envi-
ronmental conditions of the experiments. Indeed, in the pig ligated loop model the animals were
fasted, which is consistent with the fact that toxin production is inversely correlated to nutrient
availability. Importantly, we observed for the first time that the binary toxin genes are expressed
during infection, supporting their role as potential virulence factors as already suggested [40].
In monoxenic mice, despite the imperfection of this model due to the absence of the com-
petitive microbiota for the nutrient sources, the coordinate upregulation of genes involved in
transport and metabolism of specific polysaccharides and amino acids may reflect the flexibility
in nutrient acquisition by strain R20291. The upregulation of the PTS genes of cellobiose, a
disaccharide produced by degradation of cellulose, and galactitol supports the notion that these
sugars are present in the mouse digestive tract. Interestingly, several PTS-encoding genes were
upregulated early or late during infection while others were downregulated such as ribose-spe-
cific PTS (CDR0303-0305) (Table D in S1 File). This may be explained either by the absence of
these sugars in the gut content or by carbon sources being preferred over these substrates in
strain R20291. Furthermore, we found that genes associated with the pentose phosphate path-
way leading to the formation of glucolysis intermediates were induced in strain R20291 but not
in strain 630. Also, whereas ethanolamine can be used as carbon and/or nitrogen sources in the
gastro-intestinal lifestyle of strain 630 [12], in strain R20291, the eut operon (CDR1828-1846)
involved in ethanolamine degradation was not regulated overtime indicating that ethanol-
amine is probably not used as a nutrient source by this strain. In addition, unlike strain 630,
the nagAB genes (CDR0866-0867) coding for enzymes responsible for degradation of N-acetyl-
glucosamine present in gastrointestinal mucins were upregulated at 14h in strain R20291. Thus
the ability to use these different polysaccharides seems to indicate the capacity of the 027 strain
to adapt its metabolism to the intestinal environment providing more advantages for coloniza-
tion and multiplication compared to other bacteria. This is consistent with the in vitro compe-
tition assays in fecal bioreactors and in vivo studies in humanized microbiota mice, which
recently demonstrated that PCR-ribotype 027 strains could outcompete strains from other
ribotypes [41]. Thus these metabolic features associated with virulence factors and antibiotic
resistance may participate in the epidemicity and the so-called hypervirulence of C. difficile 027
strains.
C. difficile can use amino acids as an energy source, through Stickland reactions [25]. Stick-
land reactions consist of the coupled fermentation of two amino acids in which one acts as an
electron donor (leucine, isoleucine and alanine) while another acts as an electron acceptor
(proline and glycine). In contrast to what was observed with strain 630, for which the leucine-
proline appeared to be the Stickland pair preferentially used in vivo by this strain to generate
ATP [12], no clear trends have evidenced suggesting that strain R20291 is able to use any pair
in an equivalent way (Table E in S1 File).
Spores are the main forms of the contamination and dissemination of the C. difficile infec-
tion. Our transcriptional analysis clearly showed that spore production occurred in vivo in our
monoxenic mouse model. Despite the lack of sporulation synchronization impeding data inter-
pretation, our results suggest that part of vegetative cells set up in the mouse caeca are engaged
rapidly in the sporulation process, as already observed for strain 630. For strain R20291 in this
animal model, the sporulation process took place as early as 6h post-challenge. However, the
sporulation rate (i.e. the ratio between spores and vegetative cells) measured for strain 630 was
higher than for strain R20291: 50% versus 1% respectively at 38h post-infection (Fig 4). This
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sporulation rate is clearly in favor of vegetative cells for strain R20291, and this could contrib-
ute to the hypervirulence of the 027 strains [12].
Expression of sporulation encoding genes were also reported in the pig ligated loop, which
replicates the more complex environment that C. difficile encounters during natural infection
in humans [39]. This suggests that signals triggering sporulation are not exclusively associated
with the microbiota activity or the lack of nutrient. The different sporulation rates between the
R20291 and 630 strains observed in the same gut environment may reflect the different capac-
ity of strains to sense the complex in vivo signals that promote C. difficile sporulation. Of note,
the App transporter (CDR2558-2562) that has been shown to inhibit sporulation in C. difficile
by facilitating the uptake of peptides and thus the availability to nutrients [42] was earlier and
much more upregulated during infection in strain R20291 than in strain 630. This may account
for the quite low sporulation rate observed in vivo in strain R20291.
Finally, several genes encoding proteins with unknown functions were differentially regu-
lated in strain R20291 during the course of infection. Most of them are common with those
already described in strain 630 [12] but interestingly their regulation are either similar or oppo-
site (Table A in S1 File). For instance, CDR1478 (CD1581) encoding CdeM protein recently
found to be associated to the exosporium layer in strain 630 [43] was highly upregulated late in
R20291 and 630 strains. Similar upregulation in both strains were also observed for CDR0197
(CD0196), CDR0926 (CD1067) and CDR1962 (CD2055) genes, while some genes were more
upregulated in strain R20291 such as CDR1511 (CD1613) and CDR3482 (CD3620). In addi-
tion, CDR0706-0709 and CDR2235 were only upregulated in strain R20291. Thus strain
R20291 genes specifically upregulated during the infection process could participate in the
hypervirulence of this 027 epidemic strain.
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